Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
600.71
-14.07 (-2.29%)
At close: Jun 1, 2026, 4:00 PM EDT
600.01
-0.70 (-0.12%)
After-hours: Jun 1, 2026, 4:12 PM EDT

Regeneron Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
61,12981,58778,07196,08579,07568,631
Market Cap Growth
-0.90%4.50%-18.75%21.51%15.22%33.09%
Enterprise Value
45,41375,68771,76387,94374,03464,916
Last Close Price
600.71771.87712.33878.29721.49631.52
PE Ratio
14.9718.6118.5825.2618.888.77
Forward PE
12.6817.1115.1919.3617.2911.00
PEG Ratio
1.172.930.954.75--
PS Ratio
4.115.695.507.336.504.27
PB Ratio
1.992.612.663.703.493.66
P/TBV Ratio
2.062.682.793.853.613.78
P/FCF Ratio
14.8919.9921.3024.7917.8710.51
P/OCF Ratio
12.2216.3917.6620.9215.779.69
EV/Sales Ratio
3.045.285.056.706.084.04
EV/EBITDA Ratio
10.3618.3616.0419.6814.577.03
EV/EBIT Ratio
11.8221.1517.9821.7315.627.26
EV/FCF Ratio
11.0418.5519.5822.6916.739.94
Debt / Equity Ratio
0.060.090.090.100.120.11
Debt / EBITDA Ratio
0.650.660.610.610.530.29
Debt / FCF Ratio
0.660.660.740.700.610.41
Net Debt / Equity Ratio
-0.19-0.19-0.21-0.31-0.22-0.16
Net Debt / EBITDA Ratio
-1.45-1.43-1.41-1.82-0.99-0.32
Net Debt / FCF Ratio
-1.47-1.45-1.72-2.10-1.14-0.46
Asset Turnover
0.370.370.400.420.450.75
Inventory Turnover
0.730.670.700.730.721.26
Quick Ratio
2.843.283.864.824.162.98
Current Ratio
3.574.134.735.695.063.56
Return on Equity (ROE)
14.11%14.87%15.95%16.26%20.94%54.21%
Return on Assets (ROA)
7.65%7.87%10.40%12.23%15.49%36.37%
Return on Invested Capital (ROIC)
11.02%11.50%16.48%20.01%23.65%54.51%
Return on Capital Employed (ROCE)
10.09%10.22%12.57%14.52%19.92%49.75%
Earnings Yield
7.22%5.37%5.38%3.96%5.30%11.40%
FCF Yield
6.72%5.00%4.69%4.03%5.60%9.51%
Dividend Yield
0.63%0.46%0.00%0.00%0.00%0.00%
Payout Ratio
8.86%8.22%0.00%0.00%0.00%0.00%
Buyback Yield / Dilution
5.61%5.65%-1.23%-0.18%-1.16%2.52%
Total Shareholder Return
6.23%6.11%-1.23%-0.18%-1.16%2.52%
SEC Filings: 10-K · 10-Q